Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension
在达格列净/二甲双胍联合治疗方案中，依格列汀作为附加疗法治疗血糖控制不佳的2型糖尿病患者的疗效和安全性：一项为期24周的多中心、随机、安慰剂对照、平行设计的3期临床试验，并进行了28周的扩展研究。
期刊:Diabetes & Metabolism Journal
影响因子:8.5
doi:10.4093/dmj.2022.0387
Moon, Jun Sung; Park, Il Rae; Kim, Hae Jin; Chung, Choon Hee; Won, Kyu Chang; Han, Kyung Ah; Park, Cheol-Young; Won, Jong Chul; Kim, Dong Jun; Koh, Gwan Pyo; Kim, Eun Sook; Yu, Jae Myung; Hong, Eun-Gyoung; Lee, Chang Beom; Yoon, Kun-Ho
